But a new study from researchers at the University of Bristol offers fresh hope. It looks at how a well-known medicine called ...

Johnson & Johnson's Invokana (canagliflozin) meanwhile also has an indication for diabetic kidney disease, but has been ... in a different way to the SGLT2 drugs by blocking MR overactivation ...

Medscape News UK, February 27, 2025 Bone-Derived Hormone Predicts Diabetic Kidney Disease Risk Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for ...

has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, ... Researchers Find Cholesterol-Lowering Drugs Have No Effect on Kidney Function Jan.

(Nasdaq: ZVSA, or “ZyVersa”), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory ... clinical study with Cholesterol ...

Diabetic kidney disease is the leading cause of end-stage ... inhibitors have emerged as a revolutionary class of drugs in managing both diabetes and CKD. SGLT2 inhibitors, such as empagliflozin ...

Diabetic kidney disease, or diabetic nephropathy, affects 1 in 3 people with diabetes, making it a leading cause of kidney failure worldwide. But how exactly does uncontrolled sugar damage these ...

Bayer has launched a digital patient support package in England designed to help people with type 2 diabetes look after the health of their kidneys and avoid progression to chronic kidney disease ...

This study aimed to calculate the incidence of AKI due to anti-TB drugs and analyze the outcomes ... Thirty (30%) had co-morbid chronic kidney disease or end-stage renal disease.

CEO Stephen Glover said, “ZyVersa is developing Cholesterol Efflux Mediator VAR 200 for treatment of chronic kidney diseases, initially ...

The global burden of diabetic nephropathy increased from ... and future projections of the worldwide burden of chronic kidney disease (CKD) caused by type 1 and type 2 diabetes mellitus based ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...